Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin - PubMed (original) (raw)
. 1998 May 1;273(18):10823-6.
doi: 10.1074/jbc.273.18.10823.
Affiliations
- PMID: 9556553
- DOI: 10.1074/jbc.273.18.10823
Free article
Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin
S Kishida et al. J Biol Chem. 1998.
Free article
Abstract
The regulators of G protein signaling (RGS) domain of Axin, a negative regulator of the Wnt signaling pathway, made a complex with full-length adenomatous polyposis coli (APC) in COS, 293, and L cells but not with truncated APC in SW480 or DLD-1 cells. The RGS domain directly interacted with the region containing the 20-amino acid repeats but not with that containing the 15-amino acid repeats of APC, although both regions are known to bind to beta-catenin. In the region containing seven 20-amino acid repeats, the region containing the latter five repeats bound to the RGS domain of Axin. Axin and beta-catenin simultaneously interacted with APC. Furthermore, Axin stimulated the degradation of beta-catenin in COS cells. Taken together with our recent observations that Axin directly interacts with glycogen synthase kinase-3beta (GSK-3beta) and beta-catenin and that it promotes GSK-3beta-dependent phosphorylation of beta-catenin, these results suggest that Axin, APC, GSK-3beta, and beta-catenin make a tetrameric complex, resulting in the regulation of the stabilization of beta-catenin.
Similar articles
- Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T. Nakamura T, et al. Genes Cells. 1998 Jun;3(6):395-403. doi: 10.1046/j.1365-2443.1998.00198.x. Genes Cells. 1998. PMID: 9734785 - GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. Ikeda S, et al. Oncogene. 2000 Jan 27;19(4):537-45. doi: 10.1038/sj.onc.1203359. Oncogene. 2000. PMID: 10698523 - Modulation of Wnt signaling by Axin and Axil.
Kikuchi A. Kikuchi A. Cytokine Growth Factor Rev. 1999 Sep-Dec;10(3-4):255-65. doi: 10.1016/s1359-6101(99)00017-9. Cytokine Growth Factor Rev. 1999. PMID: 10647780 Review. - New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C, Sun TQ, Williams LT. Sakanaka C, et al. Recent Prog Horm Res. 2000;55:225-36. Recent Prog Horm Res. 2000. PMID: 11036939 Review.
Cited by
- The CK1ε/SIAH1 axis regulates AXIN1 stability in colorectal cancer cells.
Yan M, Su Z, Pang X, Wang H, Dai H, Ning J, Liu S, Sun Q, Song J, Zhao X, Lu D. Yan M, et al. Mol Oncol. 2024 Sep;18(9):2277-2297. doi: 10.1002/1878-0261.13624. Epub 2024 Feb 28. Mol Oncol. 2024. PMID: 38419282 Free PMC article. - The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans.
Korswagen HC, Coudreuse DY, Betist MC, van de Water S, Zivkovic D, Clevers HC. Korswagen HC, et al. Genes Dev. 2002 May 15;16(10):1291-302. doi: 10.1101/gad.981802. Genes Dev. 2002. PMID: 12023307 Free PMC article. - Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.
Guo Z, Dose M, Kovalovsky D, Chang R, O'Neil J, Look AT, von Boehmer H, Khazaie K, Gounari F. Guo Z, et al. Blood. 2007 Jun 15;109(12):5463-72. doi: 10.1182/blood-2006-11-059071. Epub 2007 Feb 22. Blood. 2007. PMID: 17317856 Free PMC article. - Abundance, complexation, and trafficking of Wnt/beta-catenin signaling elements in response to Wnt3a.
Yokoyama N, Yin D, Malbon CC. Yokoyama N, et al. J Mol Signal. 2007 Oct 25;2:11. doi: 10.1186/1750-2187-2-11. J Mol Signal. 2007. PMID: 17961224 Free PMC article. - Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.
Camilli TC, Weeraratna AT. Camilli TC, et al. Biochem Pharmacol. 2010 Sep 1;80(5):702-11. doi: 10.1016/j.bcp.2010.03.002. Epub 2010 Mar 6. Biochem Pharmacol. 2010. PMID: 20211149 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous